http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101593756-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F15-0046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F15-00 |
| filingDate | 2013-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101593756-B1 |
| titleOfInvention | Novel tetranuclear arene-Ru based metalla-bowls compound and pharmaceutical composition for preventing or treating cancer containing the same as active ingredient |
| abstract | The present invention relates to a novel 4-nuclear arene-ruthenium-based bowel compound or a pharmaceutically acceptable salt thereof, which is useful for the treatment of human HCT-15 (rectal cancer), SK-hep-1 (liver cancer) and AGS Inhibits proliferation at a low micromolar concentration, exhibits excellent anticancer activity by inhibiting the activity of cancer cells by increasing the expression of a tumor suppressor, and thus can be effectively used for prevention and treatment of cancer. |
| priorityDate | 2013-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.